PALB2 as a factor to predict the prognosis of patients with skull base chordoma

RT @tzkeong: Chordoma is a rare bone tumor (1/1mil people). Prior works noted that HRD and deletions of chromatin remodelers may lead to i…

Chordoma is a rare bone tumor (1/1mil people). Prior works noted that HRD and deletions of chromatin remodelers may lead to increased disease susceptibility in European patients. Here, elevated PALB2 levels was observed to be associated with poorer progno

New research: PALB2 as a factor to predict the prognosis of patients with skull base chordoma: Objective This study aimed to study the role of PALB2 on the prognosis of skull base chordoma patients and the proliferation, migration, and… https://t.co/HDX0U